Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Garcia-Saenz JA, Martinez-Janez N, Cubedo R, Jerez Y, Lahuerta A, Gonzalez-Santiago S, Ferrer N, Ramos M, Alonso-Romero JL, Anton A, Carrasco E, Chen J, Neuwirth R, Galinsky K, Vincent S, Leonard EJ, Slamon D. Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor. Clin Cancer Res. 2022 Mar 15;28(6):1107-1116. doi: 10.1158/1078-0432.CCR-21-2652. PubMed PMID: 34980598; PubMed Central PMCID: PMC9365359.
AÑO: 2022; IF: 11.5
Javaloyes N, Crespo A, Redal MC, Brugarolas A, Botella L, Escudero-Ortiz V, Sureda M. Psycho-Oncological Intervention Through Counseling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine (COUNTHY, NCT05054634): A Non-randomized Controlled Study. Front Psychol. 2022 Feb 25;13:767093. doi: 10.3389/fpsyg.2022.767093. eCollection 2022. PubMed PMID: 35282223; PubMed Central PMCID: PMC8914112.
AÑO: 2022; IF: 3.8
Sanchez Martinez DA, Salas-Lucia F, Jiang H, Ruiz-Carreno P, Alonso Romero JL. Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact. BMC Health Serv Res. 2022 Jul 26;22(1):948. doi: 10.1186/s12913-022-08222-9. PubMed PMID: 35883128; PubMed Central PMCID: PMC9316356.
AÑO: 2022; IF: 2.908
Escudero-Ortiz V, Dominguez-Lenero V, Catalan-Latorre A, Rebollo-Liceaga J, Sureda M. Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study. Pharmaceutics. 2022 Jun 8;14(6):1216. doi: 10.3390/pharmaceutics14061216. PubMed PMID: 35745789; PubMed Central PMCID: PMC9228468.
AÑO: 2022; IF: 6.525
Sanchez Martinez DA, Canadilla-Ferreira M, Henarejos PS, Alonso Romero JL. Analysis of adolescent oncology cases from 2008 through 2018 in a tertiary-level hospital: an opportunity for improvement. Future Oncol. 2021 Apr;17(12):1545-1551. doi: 10.2217/fon-2020-0475. Epub 2021 Feb 25. PubMed PMID: 33626935.
AÑO: 2021; IF: 3.674
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII